Structural insights into opposing actions of neurosteroids on GABAA receptors

Abstract γ-Aminobutyric acid type A (GABAA) receptors mediate fast inhibitory signaling in the brain and are targets of numerous drugs and endogenous neurosteroids. A subset of neurosteroids are GABAA receptor positive allosteric modulators; one of these, allopregnanolone, is the only drug approved...

Full description

Bibliographic Details
Main Authors: Dagimhiwat H. Legesse, Chen Fan, Jinfeng Teng, Yuxuan Zhuang, Rebecca J. Howard, Colleen M. Noviello, Erik Lindahl, Ryan E. Hibbs
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-40800-1
_version_ 1827710055834714112
author Dagimhiwat H. Legesse
Chen Fan
Jinfeng Teng
Yuxuan Zhuang
Rebecca J. Howard
Colleen M. Noviello
Erik Lindahl
Ryan E. Hibbs
author_facet Dagimhiwat H. Legesse
Chen Fan
Jinfeng Teng
Yuxuan Zhuang
Rebecca J. Howard
Colleen M. Noviello
Erik Lindahl
Ryan E. Hibbs
author_sort Dagimhiwat H. Legesse
collection DOAJ
description Abstract γ-Aminobutyric acid type A (GABAA) receptors mediate fast inhibitory signaling in the brain and are targets of numerous drugs and endogenous neurosteroids. A subset of neurosteroids are GABAA receptor positive allosteric modulators; one of these, allopregnanolone, is the only drug approved specifically for treating postpartum depression. There is a consensus emerging from structural, physiological and photolabeling studies as to where positive modulators bind, but how they potentiate GABA activation remains unclear. Other neurosteroids are negative modulators of GABAA receptors, but their binding sites remain debated. Here we present structures of a synaptic GABAA receptor bound to allopregnanolone and two inhibitory sulfated neurosteroids. Allopregnanolone binds at the receptor-bilayer interface, in the consensus potentiator site. In contrast, inhibitory neurosteroids bind in the pore. MD simulations and electrophysiology support a mechanism by which allopregnanolone potentiates channel activity and suggest the dominant mechanism for sulfated neurosteroid inhibition is through pore block.
first_indexed 2024-03-10T17:31:48Z
format Article
id doaj.art-9c3fd95d1605447bb8e398d6acc64164
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-10T17:31:48Z
publishDate 2023-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-9c3fd95d1605447bb8e398d6acc641642023-11-20T09:59:43ZengNature PortfolioNature Communications2041-17232023-08-0114111310.1038/s41467-023-40800-1Structural insights into opposing actions of neurosteroids on GABAA receptorsDagimhiwat H. Legesse0Chen Fan1Jinfeng Teng2Yuxuan Zhuang3Rebecca J. Howard4Colleen M. Noviello5Erik Lindahl6Ryan E. Hibbs7Department of Neuroscience, UT Southwestern Medical CenterDept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm UniversityDepartment of Neurobiology, University of California San DiegoDept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm UniversityDept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm UniversityDepartment of Neurobiology, University of California San DiegoDept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm UniversityDepartment of Neuroscience, UT Southwestern Medical CenterAbstract γ-Aminobutyric acid type A (GABAA) receptors mediate fast inhibitory signaling in the brain and are targets of numerous drugs and endogenous neurosteroids. A subset of neurosteroids are GABAA receptor positive allosteric modulators; one of these, allopregnanolone, is the only drug approved specifically for treating postpartum depression. There is a consensus emerging from structural, physiological and photolabeling studies as to where positive modulators bind, but how they potentiate GABA activation remains unclear. Other neurosteroids are negative modulators of GABAA receptors, but their binding sites remain debated. Here we present structures of a synaptic GABAA receptor bound to allopregnanolone and two inhibitory sulfated neurosteroids. Allopregnanolone binds at the receptor-bilayer interface, in the consensus potentiator site. In contrast, inhibitory neurosteroids bind in the pore. MD simulations and electrophysiology support a mechanism by which allopregnanolone potentiates channel activity and suggest the dominant mechanism for sulfated neurosteroid inhibition is through pore block.https://doi.org/10.1038/s41467-023-40800-1
spellingShingle Dagimhiwat H. Legesse
Chen Fan
Jinfeng Teng
Yuxuan Zhuang
Rebecca J. Howard
Colleen M. Noviello
Erik Lindahl
Ryan E. Hibbs
Structural insights into opposing actions of neurosteroids on GABAA receptors
Nature Communications
title Structural insights into opposing actions of neurosteroids on GABAA receptors
title_full Structural insights into opposing actions of neurosteroids on GABAA receptors
title_fullStr Structural insights into opposing actions of neurosteroids on GABAA receptors
title_full_unstemmed Structural insights into opposing actions of neurosteroids on GABAA receptors
title_short Structural insights into opposing actions of neurosteroids on GABAA receptors
title_sort structural insights into opposing actions of neurosteroids on gabaa receptors
url https://doi.org/10.1038/s41467-023-40800-1
work_keys_str_mv AT dagimhiwathlegesse structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors
AT chenfan structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors
AT jinfengteng structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors
AT yuxuanzhuang structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors
AT rebeccajhoward structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors
AT colleenmnoviello structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors
AT eriklindahl structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors
AT ryanehibbs structuralinsightsintoopposingactionsofneurosteroidsongabaareceptors